Form 4 for VRDN Viridian Therapeutics, Inc.\DE
Accepted 2021-09-23 00:00:00 ET · period of report 2021-09-21 · accession 0000899243-21-037255 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-09-23 | 2021-09-21 | VRDN | Fairmount Healthcare Fund L.P. | Dir, See Remarks | P - Purchase | $11.00 | +909.0K | 938.2K | +3,109% | +$10.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-21 | P | A | 909,000 | $11.00 | 938,233 | I Fairmount Healthcare Fund II LP | — | — | (F2) Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the shares of Common Stock and Series A Non-Voting Convertible Preferred Stock held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein. |